Los Angeles, United States
DNA37 specializes in genetic testing services, with a focus on personal wellness optimization through DNA sequencing and genomics. Founded in 2016 and headquartered in the United States, the company, formerly known as Genomics DNA, has established itself in the Biotechnology sector.
The startup leverages its expertise in biotechnology to develop products that integrate genetic insights into daily wellness routines. Through its home kits, DNA37 aims to simplify access to genomic data for individuals seeking personalized health insights.
Despite its promising potential, the company has not secured any significant funding rounds since a $50.00K Pre Seed Round investment on 05 February 2017. No investors from this round have been disclosed. The absence of recent funding could suggest a cautious approach to scaling or potential challenges in gaining investor traction. Nevertheless, with the rising interest in personalized medicine, DNA37 may present an attractive opportunity for investors looking to capitalize on innovations in the wellness space through genomics.
Personal Genomics
